Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 3/20 | 0.64 |
| ▸ | LMNA | P02545 | 2/20 | 0.54 |
| ▸ | KLKB1 | P03952 | 1/20 | 0.52 |
| ▸ | F10 | P00742 | 3/20 | 0.50 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.50 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.48 |
| ▸ | CNR1 | P21554 | 2/20 | 0.48 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | CNR2 | P34972 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15363130 | 0.75 | L3MBTL1 (0.66) | LMNAKLKB1F10HDAC1HDAC2 | |
| SCHEMBL13753339 | 0.74 | LMNA (0.70) | LMNAKLKB1F10HDAC1HDAC2 | |
| SCHEMBL24273334 | 0.72 | CNR1 (0.59) | LMNAKLKB1F10HDAC1HDAC2 | |
| SCHEMBL8230799 | 0.72 | F10 (0.84) | LMNAKLKB1F10HDAC1HDAC2 | |
| SCHEMBL4920626 | 0.71 | TAS1R3 (0.58) | LMNAKLKB1F10MAPK1PTPN7 | |
| SCHEMBL13276970 | 0.70 | F10 (0.66) | LMNAKLKB1F10HDAC1HDAC2 | |
| SCHEMBL13276969 | 0.70 | F10 (0.66) | LMNAKLKB1F10HDAC1HDAC2 | |
| SCHEMBL28512721 | 0.70 | ADORA1 (0.69) | LMNAL3MBTL1MAPK1CNR1ADORA1 | |
| SCHEMBL28462852 | 0.70 | L3MBTL1 (0.65) | LMNAHDAC1HDAC2L3MBTL1MAPK1 | |
| SCHEMBL5852445 | 0.70 | NPSR1 (0.81) | LMNAL3MBTL1MAPK1CNR1ADORA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250099482-A1 | TIP60 NEURO-EPIGENETIC MODULATORS | DREXEL UNIVERSITY | 2025-03-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250099482-A1 | TIP60 NEURO-EPIGENETIC MODULATORS | MECP2, EP300, EHMT1 | CYP19A1 4413/4885LMNA 2264/4885KLKB1 3941/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.